1991
DOI: 10.1248/cpb.39.112
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1(HIV-1) and herpes simplex virus type 1(HSV-1) in vitro.

Abstract: Chemically modified compounds of glycyrrhizin have been synthesized and evaluated for their inhibitory effect on the replication of human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1). Among them, the 11-deoxo compound having a heteroannular diene structure at the C and D rings proved as active against HIV-1 as glycyrrhizin in MT-4 and MOLT-4 cells. It completely inhibited HIV-1-induced cytopathogenicity in both cell lines at a concentration of 0.16 mM. The compound was also eff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
64
0

Year Published

1991
1991
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 92 publications
(65 citation statements)
references
References 0 publications
1
64
0
Order By: Relevance
“…It has in-vitro and in-vivo antiviral activity, interfering with DNA and RNA replication of a wide range of viruses, including herpes, influenza A and B, hepatitis B, coronavirus, and SARS (Pompei, et al, 1979;Hirabayashi et al, 1991;Badam, 1994;Lin, 2003;Hoever, et al 2005;Lee, et al, 2007). This pharmaceutical preparation has also been demonstrated to be able to prevent the virion from hatching from its capsid (Pompei, et al, 1979;Lin, 2003), apparently due to a dose-dependent inhibition of kinase-P phosphorylation (Chavali, et al, 1987;Ohtsuki and Ishida, 1988).…”
Section: Introductionmentioning
confidence: 99%
“…It has in-vitro and in-vivo antiviral activity, interfering with DNA and RNA replication of a wide range of viruses, including herpes, influenza A and B, hepatitis B, coronavirus, and SARS (Pompei, et al, 1979;Hirabayashi et al, 1991;Badam, 1994;Lin, 2003;Hoever, et al 2005;Lee, et al, 2007). This pharmaceutical preparation has also been demonstrated to be able to prevent the virion from hatching from its capsid (Pompei, et al, 1979;Lin, 2003), apparently due to a dose-dependent inhibition of kinase-P phosphorylation (Chavali, et al, 1987;Ohtsuki and Ishida, 1988).…”
Section: Introductionmentioning
confidence: 99%
“…In order to confirm these activities, many studies concerning the constituents of these plants have been conducted. This has led to the isolation of several compounds with anti-HIV activity, such as glycyrrhizin (Mori et al, 1990;Hirabayashi et al, 1991;Badam, 1994), hypericin (Farnet et al, 1998;Gulick et al, 1999), and several polysaccharides (Gollapudi et al, 1995;Nakano et al, 1997), lectins (Balzarini et al, 1992), polyphenols (Hashimoto et al, 1996) and diterpenes (Paris et al, 1993).…”
Section: Discussionmentioning
confidence: 99%
“…12 Glycyrrhizic acid has been shown to possess in vitro and in vivo antiviral activity interfering with both DNA and RNA replication. [9][10][11][12][13] As in this trial, other authors have also proposed antiviral activity for glycyrrhizic acid. 8,[10][11][12]14 However, the precise manner in which this action is achieved is not known.…”
Section: Original Researchmentioning
confidence: 99%
“…8 It is already available in the human market, and it is commercialized as a nutraceutical preparation mixed with antioxidants, vitamins and oligoelements (Viusid®, from Catalysis, Spain; distributed by Dermaceutical México, SA de CV Mexico City). Glycyrrhizic acid has been shown to possess in vitro and in vivo antiviral activity that interferes with both DNA and RNA replication, thus interfering with the replication of a wide range of viruses, including herpes, influenza A and B, hepatitis B, coronavirus and SARS [9][10][11][12][13][14] Glycyrrhizic acid and derivatives have been shown to be able to impede the release of virions from their capsids, 14 apparently due to a dose-dependent inhibition of protein kinase P phosphorylation 15,16 and perhaps due to its ability to decrease membrane fluidity. 8 Likewise, glycyrrhizic acid interferes with arylamine N-acetyltransferase activity in bacteria, thus showing antibacterial effects against at least Streptococcus spp., Haemophilus spp., and Klebsiella spp.…”
Section: Introductionmentioning
confidence: 99%